{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:28:43Z","timestamp":1793413723490,"version":"4.5.0"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7511a1","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:27:14Z","timestamp":1774524434000},"page":"139-145","source":"Crossref","is-referenced-by-count":18,"title":["Increases in Kratom-Related Reports to Poison Centers \u2014 National Poison Data System, United States, 2015\u20132025"],"prefix":"10.15585","volume":"75","author":[{"given":"Eleanor Blair","family":"Towers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ynhi T.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Holstege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R1","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacology"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R3","doi-asserted-by":"publisher","DOI":"10.54119\/jflp.rvjg5570","article-title":"The marketing of self-care and alternative therapies in the U.S. in 2019: how industry stakeholders appeal to consumers\u2019 perceptions of novel food products and additives.","volume":"15.","author":"Glover","year":"2020","journal-title":"J Food Law Policy"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/13880209.2025.2590311","article-title":"From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat.","volume":"63","author":"Alsbrook","year":"2025","journal-title":"Pharm Biol"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R5","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health (NSDUH): key resources and tools for NSDUH. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2025. Accessed July 27, 2025. https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R6","unstructured":"US Food and Drug Administration. Import Alert 54\u201315: detention without physical examination of dietary supplements and bulk dietary ingredients that are or contain kratom (\n                      Mitragyna speciosa\n                      ). Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2026. https:\/\/www.accessdata.fda.gov\/cms_ia\/importalert_1137.html"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/17425255.2025.2521045","article-title":"Evaluating the drug interactions in kratom usage: clinical application.","volume":"21","author":"Dhoble","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R8","doi-asserted-by":"publisher","first-page":"21br02930","DOI":"10.4088\/pcc.21br02930","article-title":"Prevalence of kratom use and co-occurring substance use disorders in the United States","volume":"23","author":"Xu","year":"2021","journal-title":"Prim Care Companion CNS Disord"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of Kratom use and health impact in the US\u2014results from an online survey.","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"key-10.15585\/mmwr.mm7511a1-202603260726-R10","unstructured":"US Food and Drug administration. FDA takes steps to testrict 7-OH opioid products threatening American consumers [Press release]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2026.https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:27:17Z","timestamp":1774524437000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/75\/wr\/mm7511a1.htm?s_cid=mm7511a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7511a1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,26]]},"published":{"date-parts":[[2026,3,26]]}}}